A unique collection of tissue samples provided by people with chronic myelogenous leukemia was the driving force behind the discovery of potentially major new therapeutic approaches to drug-resistant leukemia. This study was supported by the HCI Hematology Biobank at the Huntsman Cancer Institute (HCI) at the University of Utah.
Researchers have found that laboratory studies of specially designed gas formulations composed of charged, highly reactive molecules, called “cold atmospheric plasma” or CAP, protect healthy cells nearby. It reports that it was very effective in targeting drug-resistant leukemia cells.
Click here to read more.